Billings Clinic
Especially For:

Clinical Trials

Title   Melanoma: N0879 metastatic Stage II-III post wide excision
Description   NCCTG N0879 A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma
IRB Number   N0879
Category   Melanoma
Inclusion/Notes   May have had 1 previous treatmtent for metastaic disease(but not taxane) No prior VEGF, Targeting VEGFR, or mTOR therapies. NO Brain METS, lung insufficeny, other ca > 5 yr,
Status   Active
Start Date   02/01/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (000) 000-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.